Filing Details

Accession Number:
0001493152-24-004372
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-30 19:33:47
Reporting Period:
2024-01-26
Accepted Time:
2024-01-30 19:33:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1574094 Renovorx Inc. RNXT Pharmaceutical Preparations (2834) 271448452
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1862617 Ramtin Agah 4546 El Camino Real, Suite B1
Los Altos CA 94022
Chief Medical Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-26 40,983 $0.00 47,460 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Acquisiton 2024-01-26 40,983 $0.00 40,983 $1.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,983 No 4 P Direct
Footnotes
  1. Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. These warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.